UniProt ID | PR38A_HUMAN | |
---|---|---|
UniProt AC | Q8NAV1 | |
Protein Name | Pre-mRNA-splicing factor 38A | |
Gene Name | PRPF38A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 312 | |
Subcellular Localization | Nucleus . | |
Protein Description | May be required for pre-mRNA splicing.. | |
Protein Sequence | MANRTVKDAHSIHGTNPQYLVEKIIRTRIYESKYWKEECFGLTAELVVDKAMELRFVGGVYGGNIKPTPFLCLTLKMLQIQPEKDIIVEFIKNEDFKYVRMLGALYMRLTGTAIDCYKYLEPLYNDYRKIKSQNRNGEFELMHVDEFIDELLHSERVCDIILPRLQKRYVLEEAEQLEPRVSALEEDMDDVESSEEEEEEDEKLERVPSPDHRRRSYRDLDKPRRSPTLRYRRSRSRSPRRRSRSPKRRSPSPRRERHRSKSPRRHRSRSRDRRHRSRSKSPGHHRSHRHRSHSKSPERSKKSHKKSRRGNE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Ubiquitination | -MANRTVKDAHSIHG -CCCCCCCCCHHHCC | 48.89 | 29967540 | |
7 | Methylation | -MANRTVKDAHSIHG -CCCCCCCCCHHHCC | 48.89 | 115975741 | |
11 | Phosphorylation | RTVKDAHSIHGTNPQ CCCCCCHHHCCCCHH | 20.28 | 23401153 | |
15 | Phosphorylation | DAHSIHGTNPQYLVE CCHHHCCCCHHHHHH | 29.57 | 20873877 | |
22 (in isoform 2) | Phosphorylation | - | 35.62 | - | |
23 | Acetylation | NPQYLVEKIIRTRIY CHHHHHHHHHHHHHH | 35.63 | 19608861 | |
23 | Ubiquitination | NPQYLVEKIIRTRIY CHHHHHHHHHHHHHH | 35.63 | 22817900 | |
23 (in isoform 1) | Ubiquitination | - | 35.63 | 21890473 | |
39 (in isoform 2) | Phosphorylation | - | 3.25 | - | |
66 | Ubiquitination | GVYGGNIKPTPFLCL CCCCCCCCCCHHHHE | 47.00 | - | |
68 | Phosphorylation | YGGNIKPTPFLCLTL CCCCCCCCHHHHEEH | 22.98 | 20068231 | |
73 (in isoform 2) | Phosphorylation | - | 7.36 | - | |
74 | Phosphorylation | PTPFLCLTLKMLQIQ CCHHHHEEHHHHHCC | 24.28 | 20068231 | |
75 (in isoform 2) | Phosphorylation | - | 1.66 | - | |
92 (in isoform 2) | Phosphorylation | - | 60.65 | - | |
92 | Sumoylation | DIIVEFIKNEDFKYV CEEEEECCCCCHHHH | 60.65 | - | |
92 | Acetylation | DIIVEFIKNEDFKYV CEEEEECCCCCHHHH | 60.65 | 26051181 | |
92 | Sumoylation | DIIVEFIKNEDFKYV CEEEEECCCCCHHHH | 60.65 | - | |
94 (in isoform 2) | Phosphorylation | - | 60.88 | - | |
97 | Ubiquitination | FIKNEDFKYVRMLGA ECCCCCHHHHHHHHH | 55.98 | - | |
97 | Acetylation | FIKNEDFKYVRMLGA ECCCCCHHHHHHHHH | 55.98 | 25825284 | |
105 (in isoform 2) | Phosphorylation | - | 3.07 | - | |
107 (in isoform 2) | Phosphorylation | - | 2.70 | - | |
109 (in isoform 2) | Phosphorylation | - | 2.70 | - | |
118 | Acetylation | GTAIDCYKYLEPLYN CCHHHHHHHHHHHHH | 50.09 | 26051181 | |
118 | Ubiquitination | GTAIDCYKYLEPLYN CCHHHHHHHHHHHHH | 50.09 | - | |
129 | Ubiquitination | PLYNDYRKIKSQNRN HHHHCHHHHHHCCCC | 48.54 | 29967540 | |
158 | Glutathionylation | LLHSERVCDIILPRL HHCHHCCHHHHHHHH | 3.78 | 22555962 | |
169 | Phosphorylation | LPRLQKRYVLEEAEQ HHHHHHHHHHHHHHH | 19.20 | 18452278 | |
182 | Phosphorylation | EQLEPRVSALEEDMD HHHCHHHHHHHHCHH | 28.54 | 23927012 | |
193 | Phosphorylation | EDMDDVESSEEEEEE HCHHHHHCCHHHHHH | 42.79 | 23927012 | |
194 | Phosphorylation | DMDDVESSEEEEEED CHHHHHCCHHHHHHH | 35.21 | 23927012 | |
209 | Phosphorylation | EKLERVPSPDHRRRS HHHHCCCCCCHHCCC | 39.85 | 29255136 | |
216 | Phosphorylation | SPDHRRRSYRDLDKP CCCHHCCCCCCCCCC | 23.78 | 28355574 | |
217 | Phosphorylation | PDHRRRSYRDLDKPR CCHHCCCCCCCCCCC | 13.31 | 29214152 | |
226 | Phosphorylation | DLDKPRRSPTLRYRR CCCCCCCCCCHHHHH | 24.42 | 22167270 | |
228 | Phosphorylation | DKPRRSPTLRYRRSR CCCCCCCCHHHHHHH | 25.72 | 22167270 | |
231 | Phosphorylation | RRSPTLRYRRSRSRS CCCCCHHHHHHHCCC | 17.31 | 26074081 | |
234 | Phosphorylation | PTLRYRRSRSRSPRR CCHHHHHHHCCCCCC | 26.13 | 22468782 | |
236 | Phosphorylation | LRYRRSRSRSPRRRS HHHHHHHCCCCCCCC | 38.05 | 30576142 | |
238 | Phosphorylation | YRRSRSRSPRRRSRS HHHHHCCCCCCCCCC | 24.81 | 30576142 | |
243 | Phosphorylation | SRSPRRRSRSPKRRS CCCCCCCCCCCCCCC | 34.99 | 30576142 | |
245 | Phosphorylation | SPRRRSRSPKRRSPS CCCCCCCCCCCCCCC | 35.70 | 30576142 | |
250 | Phosphorylation | SRSPKRRSPSPRRER CCCCCCCCCCHHHHH | 33.49 | 27273156 | |
252 | Phosphorylation | SPKRRSPSPRRERHR CCCCCCCCHHHHHHH | 32.08 | 27273156 | |
260 | Phosphorylation | PRRERHRSKSPRRHR HHHHHHHCCCCHHHH | 31.21 | 30576142 | |
262 | Phosphorylation | RERHRSKSPRRHRSR HHHHHCCCCHHHHHH | 25.53 | 30576142 | |
268 | Phosphorylation | KSPRRHRSRSRDRRH CCCHHHHHHHHHHHH | 28.60 | 20068231 | |
270 | Phosphorylation | PRRHRSRSRDRRHRS CHHHHHHHHHHHHHH | 39.52 | 20068231 | |
277 | Phosphorylation | SRDRRHRSRSKSPGH HHHHHHHHHCCCCCC | 34.48 | 30576142 | |
279 | Phosphorylation | DRRHRSRSKSPGHHR HHHHHHHCCCCCCCH | 38.44 | 22167270 | |
281 | Phosphorylation | RHRSRSKSPGHHRSH HHHHHCCCCCCCHHH | 37.04 | 22167270 | |
287 | Phosphorylation | KSPGHHRSHRHRSHS CCCCCCHHHHCCCCC | 22.10 | 20068231 | |
292 | Phosphorylation | HRSHRHRSHSKSPER CHHHHCCCCCCCHHH | 26.45 | 24300666 | |
294 | Phosphorylation | SHRHRSHSKSPERSK HHHCCCCCCCHHHHH | 35.75 | 24300666 | |
296 | Phosphorylation | RHRSHSKSPERSKKS HCCCCCCCHHHHHHH | 34.70 | 24300666 | |
300 | Phosphorylation | HSKSPERSKKSHKKS CCCCHHHHHHHHHCC | 42.65 | 30622161 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PR38A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PR38A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PR38A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TF3C1_HUMAN | GTF3C1 | physical | 16169070 | |
DPOA2_HUMAN | POLA2 | physical | 16169070 | |
A4_HUMAN | APP | physical | 21832049 | |
U2AF1_HUMAN | U2AF1 | physical | 22365833 | |
CHERP_HUMAN | CHERP | physical | 22365833 | |
RBM39_HUMAN | RBM39 | physical | 22365833 | |
SRSF3_HUMAN | SRSF3 | physical | 22365833 | |
PR38A_HUMAN | PRPF38A | physical | 22365833 | |
DHX8_HUMAN | DHX8 | physical | 22365833 | |
RNPS1_HUMAN | RNPS1 | physical | 22365833 | |
PPIG_HUMAN | PPIG | physical | 22365833 | |
SRSF4_HUMAN | SRSF4 | physical | 22365833 | |
ZCH10_HUMAN | ZCCHC10 | physical | 22365833 | |
SRPK1_HUMAN | SRPK1 | physical | 22365833 | |
SRPK2_HUMAN | SRPK2 | physical | 22365833 | |
JMJD6_HUMAN | JMJD6 | physical | 23455924 | |
ANM5_HUMAN | PRMT5 | physical | 23455924 | |
CSK2B_HUMAN | CSNK2B | physical | 26344197 | |
MFAP1_HUMAN | MFAP1 | physical | 26344197 | |
SRSF3_HUMAN | SRSF3 | physical | 27173435 | |
MFAP1_HUMAN | MFAP1 | physical | 27173435 | |
KTU_HUMAN | DNAAF2 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-23, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193 AND SER-194, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193 AND SER-194, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193; SER-194 ANDSER-209, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193 AND SER-194, ANDMASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-209 AND SER-226, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-193; SER-194; SER-209;THR-228; SER-260; SER-262; SER-279 AND SER-281, AND MASS SPECTROMETRY. |